Mineralys Therapeutics set to raise $120M from investors to develop treatment for high blood pressure

The private stock placement, once finalized, will be the largest by a local company in the region’s life sciences industry so far this year.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks